hydroxychloroquine has been researched along with Systemic Vasculitis in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Systemic Vasculitis: A heterogeneous group of diseases characterized by inflammation and necrosis of the blood vessel walls.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxychloroquine has antithrombotic, cardiovascular, antimicrobial and antineoplastic effects, making it a potentially valuable treatment for patients with systemic vasculitis who are at risk of infections, malignancy and thrombotic events." | 6.58 | New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis. ( Casian, A; D'Cruz, DP; Sangle, SR, 2018) |
| "Hydroxychloroquine has antithrombotic, cardiovascular, antimicrobial and antineoplastic effects, making it a potentially valuable treatment for patients with systemic vasculitis who are at risk of infections, malignancy and thrombotic events." | 2.58 | New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis. ( Casian, A; D'Cruz, DP; Sangle, SR, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casian, A | 1 |
| Sangle, SR | 1 |
| D'Cruz, DP | 1 |
| Lenert, P | 1 |
| Icardi, M | 1 |
| Dahmoush, L | 1 |
| Lee, CK | 1 |
| Lee, TH | 1 |
| Lee, SH | 1 |
| Chung, IK | 1 |
| Park, SH | 1 |
| Kim, HS | 1 |
| Kim, SJ | 1 |
2 reviews available for hydroxychloroquine and Systemic Vasculitis
| Article | Year |
|---|---|
New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis.
Topics: Autoimmune Diseases; Humans; Hydroxychloroquine; Immunologic Factors; Systemic Vasculitis | 2018 |
ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review.
Topics: Acne Vulgaris; Angiography; Antibodies, Antineutrophil Cytoplasmic; Autoimmunity; Biopsy; Diagnosis, | 2013 |
1 other study available for hydroxychloroquine and Systemic Vasculitis
| Article | Year |
|---|---|
GI vasculitis associated with systemic lupus erythematosus.
Topics: Administration, Oral; Anti-Inflammatory Agents; Colon; Colonic Diseases; Colonoscopy; Diagnosis, Dif | 2010 |